Advanced CKD and gender: a multi-perspective and multi-dimensional vision

Authors

  • Anna Laura Fantuzzi Dietista già Coordinatore Nutrizione e Dietetica Aziendale, AUSL Modena, Comitato Scientifico ASAND (Associazione Scientifica Alimentazione Nutrizione e Dietetica dei Dietisti Italiani), Modena - Italy
  • Elisa Berri Dietista, Dipartimento di Cure Primarie, AUSL-IRCCS di Reggio Emilia - Italy
  • Lida Tartagliolne Dirigente Medico, UOC Nefrologia, AOU Policlinico Umberto I di Roma - Italy https://orcid.org/0000-0003-4537-0876
  • Marcora Mandreoli Comitato Tecnico Scientifico Progetto regionale PIRP (Prevenzione Insufficienza Renale Progressiva https://orcid.org/0000-0003-0117-4857
  • Rossella Giannini Dietista, SSD Malattie del Metabolismo e Nutrizione Clinica, Azienda Ospedaliero-Universitaria Policlinico di Modena - Italy
  • Sara Dominjanni Dirigente Medico, UOC Nefrologia e Dialisi Ospedale Sant’Eugenio, ASL Roma 2, Roma - Italy https://orcid.org/0000-0001-5480-3616
  • Silvia Porreca Dirigente Medico, U.O. C. di Nefrologia e Dialisi, P.O. “Di Venere”, Bari - ASL BA - Italy https://orcid.org/0000-0002-5636-1361

DOI:

https://doi.org/10.33393/gcnd.2024.3026

Keywords:

Access to healthcare, Chronic kidney disease, Dialysis treatment, Gender medicine, Women

Abstract

Chronic kidney disease (CKD) is present in approximately 7% of the population in the world: several studies have highlighted socio-cultural discrimination, to the detriment of women, in referral to specialist nephrological care and access to dialysis and transplantation. Globally, gender discrimination limits the possibility of access to education and medical care and the involvement in clinical trials. Women on dialysis have different comorbidities than men; the choice to follow a predialysis process and the subsequent orientation towards dialysis treatment are certainly influenced by gender as is the choice of dialysis access. As regards kidney transplantation, women are more likely to offer themselves as donors rather than to be beneficiaries. Conventional knowledge supports the belief that there are gender differences in the acquisition, preparation and consumption of food; for this reason it is essential to consider the variables that come into play when defining and agreeing treatment paths, in particular in taking care of people with chronic diseases such as CKD.

References

  1. De Nicola L, Donfrancesco C, Minutolo R, et al; ANMCO-SIN Research Group. Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey. Nephrol Dial Transplant. 2015;30(5):806-814. https://doi.org/10.1093/ndt/gfu383 PMID:25523453 DOI: https://doi.org/10.1093/ndt/gfu383
  2. Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151-164. https://doi.org/10.1038/nrneph.2017.181 PMID:29355169 DOI: https://doi.org/10.1038/nrneph.2017.181
  3. Mandreoli M. Influenza di genere e sesso nello sviluppo e nel decorso delle malattie renali. G Clin Nefrol Dial. 2023;35:1-7. DOI: https://doi.org/10.33393/gcnd.2023.2661
  4. United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. USRDS; 2016.
  5. Kramer A, Pippias M, Noordzij M, et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary. Clin Kidney J. 2019;12(5):702-720. https://doi.org/10.1093/ckj/sfz011 PMID:31583095 DOI: https://doi.org/10.1093/ckj/sfz011
  6. Neugarten J, Golestaneh L. Influence of sex on the progression of chronic kidney disease. Mayo Clin Proc. 2019;94(7):1339-1356. https://doi.org/10.1016/j.mayocp.2018.12.024 PMID:31272577 DOI: https://doi.org/10.1016/j.mayocp.2018.12.024
  7. Tangri N, Grams ME, Levey AS, et al. CKD Prognosis Consortium. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12;315(2):164-74. https://doi.org/10.1001/jama.2015.18202 PMID: 26757465 DOI: https://doi.org/10.1001/jama.2015.18202
  8. Minutolo R, Gabbai FB, Chiodini P, et al; Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies. Am J Kidney Dis. 2020;75(1):30-38. https://doi.org/10.1053/j.ajkd.2019.05.019 PMID:31409508 DOI: https://doi.org/10.1053/j.ajkd.2019.05.019
  9. Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: a nationwide study in Sweden. Am J Kidney Dis. 2021;78(2):190-199.e1. https://doi.org/10.1053/j.ajkd.2020.11.026 PMID:33434591 DOI: https://doi.org/10.1053/j.ajkd.2020.11.026
  10. Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol. 2024;20(1):7-20. https://doi.org/10.1038/s41581-023-00784-z PMID:37985869 DOI: https://doi.org/10.1038/s41581-023-00784-z
  11. Ciarambino T, Crispino P, Giordano M. Gender and Renal Insufficiency: Opportunities for Their Therapeutic Management? Cells. 2022;11(23):382. https://doi.org/10.3390/cells11233820 PMID:36497080 DOI: https://doi.org/10.3390/cells11233820
  12. Swartling O, Yang Y, Clase CM, et al. Sex differences in the recognition, monitoring, and management of CKD in health care: an observational cohort study. J Am Soc Nephrol. 2022;33(10):1903-1914. https://doi.org/10.1681/ASN.2022030373 PMID:35906075 DOI: https://doi.org/10.1681/ASN.2022030373
  13. Bello AK, Ronksley PE, Tangri N, et al. Quality of chronic kidney disease management in Canadian primary care. JAMA Netw Open. 2019;2(9):e1910704. https://doi.org/10.1001/jamanetworkopen.2019.10704 PMID:31483474 DOI: https://doi.org/10.1001/jamanetworkopen.2019.10704
  14. United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. https://usrds-adr.niddk.nih.gov/2023 (Accessed January 2024)
  15. Vogel SL, Singh T, Astor BC, Waheed S. Gender differences in peritoneal dialysis initiation in the US end-stage renal disease population. Perit Dial Int. 2020;40(1):57-61. https://doi.org/10.1177/0896860819878656 PMID:32063143 DOI: https://doi.org/10.1177/0896860819878656
  16. Beckwith H, Thomas N, Adwaney A, et al. Gender Differences in Experiences and Expectations of Hemodialysis in a Frail and Seriously Unwell Patient Population. Kidney Int Rep. 2022;7(11):2421-2430. https://doi.org/10.1016/j.ekir.2022.08.023 PMID:36531893 DOI: https://doi.org/10.1016/j.ekir.2022.08.023
  17. Lipnicki DM, Crawford J, Kochan NA, et al; Sydney Memory and Ageing Study Team. Risk factors for mild cognitive impairment, dementia and mortality: The Sydney Memory and Ageing Study. J Am Med Dir Assoc. 2017;18(5):388-395. https://doi.org/10.1016/j.jamda.2016.10.014 PMID:28043804 DOI: https://doi.org/10.1016/j.jamda.2016.10.014
  18. Yaffe K, Ackerson L, Kurella Tamura M, et al; Chronic Renal Insufficiency Cohort Investigators. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58(2):338-345. https://doi.org/10.1111/j.1532-5415.2009.02670.x PMID:20374407 DOI: https://doi.org/10.1111/j.1532-5415.2009.02670.x
  19. Sarnak MJ, Tighiouart H, Scott TM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80(5):471-480. https://doi.org/10.1212/WNL.0b013e31827f0f7f PMID:23303848 DOI: https://doi.org/10.1212/WNL.0b013e31827f0f7f
  20. van Zwieten A, Wong G, Ruospo M, et al; COGNITIVE-HD study investigators. Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant. 2018;33(7):1197-1206. https://doi.org/10.1093/ndt/gfx314 PMID:29186522 DOI: https://doi.org/10.1093/ndt/gfx314
  21. Liabeuf S, Pepin M, Franssen CFM, et al; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? Nephrol Dial Transplant. 2021;37(suppl 2):ii33-ii44. https://doi.org/10.1093/ndt/gfab223 PMID:34718753 DOI: https://doi.org/10.1093/ndt/gfab223
  22. Drew DA, Weiner DE, Sarnak MJ. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis. 2019;74(6):782-790. https://doi.org/10.1053/j.ajkd.2019.05.017 PMID:31378643 DOI: https://doi.org/10.1053/j.ajkd.2019.05.017
  23. Rotondi S, Tartaglione L, Pasquali M, et al. Association between Cognitive Impairment and Malnutrition in Hemodialysis Patients: Two Sides of the Same Coin. Nutrients. 2023;15(4):813. https://doi.org/10.3390/nu15040813 PMID:36839171 DOI: https://doi.org/10.3390/nu15040813
  24. Mazumder MK, Paul R, Bhattacharya P, Borah A. Neurological sequel of chronic kidney disease: from diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain. Sci Rep. 2019;9(1):3097. https://doi.org/10.1038/s41598-018-37935-3 PMID:30816118 DOI: https://doi.org/10.1038/s41598-018-37935-3
  25. Liu J, Chen K, Chen J, et al. Incidence and risk factors of cognitive dysfunction in hemodialysis patients: A systematic review and meta-analysis. Semin Dial. 2023;36(5):358-365. PMID:37592399 https://doi.org/10.1111/sdi.13171 PMID:37592399 DOI: https://doi.org/10.1111/sdi.13171
  26. Weber MT, Mapstone M, Staskiewicz J, Maki PM. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause. 2012;19(7):735-741. https://doi.org/10.1097/gme.0b013e318241fd22 PMID:22415562 DOI: https://doi.org/10.1097/gme.0b013e318241fd22
  27. Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F, Ricardo AC. Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management. Kidney Int Rep. 2016;2(1):94-107. https://doi.org/10.1016/j.ekir.2016.09.005 PMID:29318209 DOI: https://doi.org/10.1016/j.ekir.2016.09.005
  28. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Prevalence of major depressive episode in CKD. Am J Kidney Dis. 2009;54(3):424-432. https://doi.org/10.1053/j.ajkd.2009.03.017 PMID:19493599 DOI: https://doi.org/10.1053/j.ajkd.2009.03.017
  29. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006;69(9):1662-1668. https://doi.org/10.1038/sj.ki.5000308 PMID:16598203 DOI: https://doi.org/10.1038/sj.ki.5000308
  30. Lopes AA, Bragg-Gresham JL, Goodkin DA, et al. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res. 2007;16(4):545-557. https://doi.org/10.1007/s11136-006-9143-7 PMID:17286199 DOI: https://doi.org/10.1007/s11136-006-9143-7
  31. Lopes GB, Matos CM, Leite EB, et al. Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin Pract. 2010;115(1):c35-c40. https://doi.org/10.1159/000286348 PMID:20173348 DOI: https://doi.org/10.1159/000286348
  32. Hankin BL, Abramson LY. Development of gender differences in depression: an elaborated cognitive vulnerability-transactional stress theory. Psychol Bull. 2001;127(6):773-796. https://doi.org/10.1037/0033-2909.127.6.773 PMID:11726071 DOI: https://doi.org/10.1037//0033-2909.127.6.773
  33. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39(3):549-555. https://doi.org/10.1053/ajkd.2002.31405 PMID:11877574 DOI: https://doi.org/10.1053/ajkd.2002.31405
  34. Frankenfield DL, Roman SH, Rocco MV, Bedinger MR, McClellan WM. Disparity in outcomes for adult Native American hemodialysis patients? Findings from the ESRD Clinical Performance Measures Project, 1996 to 1999. Kidney Int. 2004;65(4):1426-1434. https://doi.org/10.1111/j.1523-1755.2004.00515.x PMID:15086485 DOI: https://doi.org/10.1111/j.1523-1755.2004.00515.x
  35. Markell M, Brar A, Stefanov DG, Salifu MO. Gender disparity in fistula use at initiation of hemodialysis varies markedly across ESRD networks-Analysis of USRDS data. Hemodial Int. 2018;22(2):168-175. https://doi.org/10.1111/hdi.12579 PMID:28662308 DOI: https://doi.org/10.1111/hdi.12579
  36. Shah S, Leonard AC, Meganathan K, Christianson AL, Thakar CV. Gender and Racial Disparities in Initial Hemodialysis Access and Outcomes in Incident End-Stage Renal Disease Patients. Am J Nephrol. 2018;48(1):4-14. https://doi.org/10.1159/000490624 PMID:29990994 DOI: https://doi.org/10.1159/000490624
  37. Marcus RJ, Marcus DA, Sureshkumar KK, Hussain SM, McGill RL. Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome. Gend Med. 2007;4(3):193-204. https://doi.org/10.1016/S1550-8579(07)80040-4 PMID:18022587 DOI: https://doi.org/10.1016/S1550-8579(07)80040-4
  38. Casey JR, Hanson CS, Winkelmayer WC, et al. Patients’ perspectives on hemodialysis vascular access: a systematic review of qualitative studies. Am J Kidney Dis. 2014;64(6):937-953. https://doi.org/10.1053/j.ajkd.2014.06.024 PMID:25115617 DOI: https://doi.org/10.1053/j.ajkd.2014.06.024
  39. Beathard GA, Litchfield T, Jennings WC. Two-year cumulative patency of endovascular arteriovenous fistula. J Vasc Access. 2020;21(3):350-356. https://doi.org/10.1177/1129729819877780 PMID:31566061 DOI: https://doi.org/10.1177/1129729819877780
  40. Lok CE, Rajan DK, Clement J, et al; NEAT Investigators. Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT). Am J Kidney Dis. 2017;70(4):486-497. https://doi.org/10.1053/j.ajkd.2017.03.026 PMID:28624422 DOI: https://doi.org/10.1053/j.ajkd.2017.03.026
  41. Al-Balas A, Varma R, Sharbidre K, Al-Balas H, Almehmi A, Abdel Aal AK, Robbin ML, Allon M. Feasibility of Creation of an Endovascular Arteriovenous Fistula in Patients Undergoing Preoperative Vascular Mapping. Kidney360. 2021 Oct 20;3(2):287-292. https://doi.org/10.34067/kid.0004242021 PMID: 35373141 DOI: https://doi.org/10.34067/KID.0004242021
  42. ISS – 24 maggio 2019, La Medicina di Genere https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/m/medicina-di-genere#breve-storia-della-medicina-di-genere. (Accessed January 2024)
  43. Fouque D. Why is the diet intervention so critical during chronic kidney disease? J Ren Nutr. 2003;13(3):173. CrossRef PubMed. https://doi.org/10.1016/S1051-2276(03)00077-3 PMID:12874740 DOI: https://doi.org/10.1016/S1051-2276(03)00077-3
  44. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. https://doi.org/10.1136/bmj.38875.675486.55 PMID:16790458 DOI: https://doi.org/10.1136/bmj.38875.675486.55
  45. Bellizzi V, Bedogni G, Quintaliani G. Compliance alla dieta nella insufficienza Renale Cronica Giornale Italiano di Nefrologia. 2008;25(S-42):S45-S49. https://giornaleitalianodinefrologia.it/wp-content/uploads/sites/3/pdf/storico/2008/S-42/S45-S49.pdf?x85047 (Accessed January 2024)
  46. Chatterjee JS. From compliance to concordance in diabetes. J Med Ethics. 2006;32(9):507-510. https://doi.org/10.1136/jme.2005.012138 PMID:16943329 DOI: https://doi.org/10.1136/jme.2005.012138

Most read articles by the same author(s)